We are live on ! Find out more
GG

Gleason Group Portfolio holdings

AUM $1.13B Turnover 11.23%
1-Year Est. Return 12.68%
This Fund
S&P 500
This Quarter Est. Return
-1.99%
1 Year Est. Return
+12.68%
3 Year Est. Return
+69.06%
5 Year Est. Return
+60.84%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
-$10.3M
Cap. Flow
+$13.4M
Cap. Flow %
1.33%
Top 10 Hldgs %
82.42%
Holding
241
New
16
Increased
108
Reduced
31
Closed
12
Avg Time Held
4 years
Top 10 Avg Time Held
4.3 years
Top 20 Avg Time Held
4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.38%
2 Financials 0.77%
3 Industrials 0.74%
4 Consumer Staples 0.67%
5 Energy 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SOLV icon
176
Solventum
SOLV
$15B
$8.16K ﹤0.01%
+125
New +$9.28K
2026 Q1
0 quarters
CLIR icon
177
ClearSign Technologies
CLIR
$16.7M
$7.86K ﹤0.01%
1,802
– –
2025 Q2
3 quarters
IMCV icon
178
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
$7.84K ﹤0.01%
92
-177
-66% -$15.2K
2019 Q4
25 quarters
INCY icon
179
Incyte
INCY
$23B
$7.62K ﹤0.01%
81
– –
2025 Q4
1 quarter
VIOO icon
180
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.04B
$7.32K ﹤0.01%
64
– –
2019 Q4
25 quarters
AEG icon
181
Aegon
AEG
$12.2B
$7.24K ﹤0.01%
997
-3
-0.3% -$22
2025 Q4
1 quarter
IJK icon
182
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.5B
$7.12K ﹤0.01%
71
-84
-54% -$8.63K
2019 Q4
25 quarters
CMI icon
183
Cummins
CMI
$73.3B
$7.05K ﹤0.01%
13
– –
2025 Q4
1 quarter
FELV icon
184
Fidelity Enhanced Large Cap Value ETF
FELV
$3.51B
$7.03K ﹤0.01%
201
+1
+0.5% +$36
2024 Q3
6 quarters
APTO
185
DELISTED
Aptose Biosciences, Inc.
APTO
$7.02K ﹤0.01%
4,206
– –
2022 Q1
16 quarters
GS icon
186
Goldman Sachs
GS
$260B
$6.84K ﹤0.01%
8
– –
2025 Q4
1 quarter
LH icon
187
Labcorp
LH
$26.4B
$6.67K ﹤0.01%
25
– –
2025 Q4
1 quarter
MCK icon
188
McKesson
MCK
$116B
$6.06K ﹤0.01%
7
– –
2025 Q4
1 quarter
NSC icon
189
Norfolk Southern
NSC
$73B
$5.74K ﹤0.01%
20
– –
2022 Q3
14 quarters
PFE icon
190
Pfizer
PFE
$168B
$5.53K ﹤0.01%
+197
New +$5.25K
2026 Q1
0 quarters
MOAT icon
191
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$4.83K ﹤0.01%
+50
New +$5.18K
2026 Q1
0 quarters
DEO icon
192
Diageo
DEO
$52.3B
$4.72K ﹤0.01%
63
– –
2019 Q4
25 quarters
PHM icon
193
Pultegroup
PHM
$21.5B
$4.71K ﹤0.01%
40
– –
2025 Q4
1 quarter
TRV icon
194
Travelers Companies
TRV
$80.1B
$4.7K ﹤0.01%
16
– –
2025 Q4
1 quarter
AMD icon
195
Advanced Micro Devices
AMD
$918B
$4.68K ﹤0.01%
23
– –
2025 Q4
1 quarter
TSM icon
196
TSMC
TSM
$2.19T
$4.4K ﹤0.01%
13
– –
2025 Q4
1 quarter
DLTR icon
197
Dollar Tree
DLTR
$23.3B
$4.38K ﹤0.01%
40
– –
2019 Q4
25 quarters
ALL icon
198
Allstate
ALL
$60.6B
$4.38K ﹤0.01%
21
-188
-90% -$38.5K
2019 Q4
25 quarters
GE icon
199
GE Aerospace
GE
$324B
$4.26K ﹤0.01%
15
– –
2025 Q4
1 quarter
APOG icon
200
Apogee Enterprises
APOG
$862M
$3.67K ﹤0.01%
109
– –
2022 Q2
15 quarters

Similar funds

Gleason Group's Q1 2026 Portfolio in Review

As of Q1 2026, Gleason Group held 241 positions worth $1.01B, down 1% from $1.02B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Gleason Group's Q1 2026 filing shows 16 new, 108 increased, 31 reduced and 12 closed positions. Its largest new stake was Schwab US Large-Cap Value ETF: 4,176 shares worth $127K. The largest sale was Vanguard S&P 500 ETF, an estimated $3.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 95% a quarter earlier, followed by Financials and Industrials.

  • Gleason Group's largest Q1 2026 buy was Schwab US Large-Cap Value ETF: 4,176 shares worth $127K.
  • Gleason Group added most to Vanguard Extended Market ETF in Q1 2026, an estimated $5.57M increase.
  • Gleason Group's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.5M.
  • Gleason Group fully exited Salesforce in Q1 2026, selling an estimated $232K.
  • Gleason Group's ten largest holdings make up 82% of its $1.01B portfolio in Q1 2026.
  • Gleason Group opened 16 new positions and closed 12 in Q1 2026.
  • Gleason Group's portfolio value fell 1% quarter-over-quarter to $1.01B.

Based on Gleason Group's 13F filing for Q1 2026, filed 4 May 2026.